WithdrawnPhase 2NCT06623240

HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis

Studying Juvenile idiopathic arthritis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hope Biosciences Research Foundation
Principal Investigator
Thanh Cheng, MD
Hope Biosciences Research Foundation
Intervention
allogeneic Hope Biosciences adipose-derived mesenchymal stem cells(biological)
Eligibility
2-16 years · All sexes
Timeline
2026 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06623240 on ClinicalTrials.gov

Other trials for Juvenile idiopathic arthritis

Additional recruiting or active studies for the same condition.

See all trials for Juvenile idiopathic arthritis →

← Back to all trials